Literature DB >> 3065220

HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells.

A L Davis1, J L McKenzie, D N Hart.   

Abstract

The immunophenotypes of the HLA-DR-positive leucocyte populations in normal human skin were studied using an extensive panel of monoclonal antibodies, which included antibodies from the Third International Leucocyte Differentiation Antigen Workshop (3rd LDAW). Langerhans' cells (LC) in the epidermis stained with antibodies from CD15c, Groups 10, 12a, 12b and 15, of the myeloid panel and from CD39 of the B-cell panel. However, LC did not react with CD14 antibodies or 63D3, which are frequently used to stain tissue macrophages. In addition to epidermal LC (26 cells/linear mm) a significant population of CD1a-positive cells was identified in the papillary dermis (7 cells/linear mm of overlying epidermis). The dermal HLA-DR-positive leucocytes consisted of three cell populations. The most numerous cell type stained with antibodies to monocytes/macrophages. There were fewer, though substantial, numbers of T lymphocytes (mainly CD7-negative) and the least numerous was the population of CD1a-positive cells. The CD1a-positive cells and the population of dermal cells that stain with monocyte/macrophage markers are both potential antigen-presenting cells for the skin-associated immune system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065220      PMCID: PMC1385567     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Epidermal Langerhans cells bear Fc and C3 receptors.

Authors:  G Stingl; E C Wolff-Schreiner; W J Pichler; F Gschnait; W Knapp; K Wolff
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

Review 2.  Langerhans cells: a review of their nature with emphasis on their immunologic functions.

Authors:  I Silberberg-Sinakin; R L Baer; G J Thorbecke
Journal:  Prog Allergy       Date:  1978

3.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

4.  The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin.

Authors:  J D Bos; I Zonneveld; P K Das; S R Krieg; C M van der Loos; M L Kapsenberg
Journal:  J Invest Dermatol       Date:  1987-05       Impact factor: 8.551

5.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes.

Authors:  I Silberberg-Sinakin; G J Thorbecke; R L Baer; S A Rosenthal; V Berezowsky
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

Review 6.  Human leukocyte antigens: an update on structure, function and nomenclature.

Authors:  A W Boyd
Journal:  Pathology       Date:  1987-10       Impact factor: 5.306

7.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

8.  Epidermal Langerhans cells are derived from cells originating in bone marrow.

Authors:  S I Katz; K Tamaki; D H Sachs
Journal:  Nature       Date:  1979-11-15       Impact factor: 49.962

9.  Distribution and turnover of Langerhans cells during delayed immune responses in human skin.

Authors:  G Kaplan; A Nusrat; M D Witmer; I Nath; Z A Cohn
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Isolation and characterization of human tonsil dendritic cells.

Authors:  D N Hart; J L McKenzie
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Hodgkin's cells express a novel pattern of adhesion molecules.

Authors:  P A Ellis; D N Hart; B M Colls; J C Nimmo; J E MacDonald; H B Angus
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

3.  CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells.

Authors:  U Reinhold; L Liu; J Sesterhenn; H Abken
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

Review 4.  CD4+ CD7- T cells: a separate subpopulation of memory T cells?

Authors:  U Reinhold; H Abken
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

5.  Aberrant phenotypes in Kikuchi's disease.

Authors:  Xue-Jing Wei; Xiao-Ge Zhou; Jian-Lan Xie; Xiao-Dan Zheng; Yuan-Yuan Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.

Authors:  I C Kennedy; D N Hart; B M Colls; J C Nimmo; D A Willis; H B Angus
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells.

Authors:  L Liu; H Abken; C Pföhler; G Rappl; W Tilgen; U Reinhold
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 8.  Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G.

Authors:  Guillaume Mestrallet; Nathalie Rouas-Freiss; Joel LeMaoult; Nicolas O Fortunel; Michele T Martin
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

9.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.